Live feed/
Filings
/
SCHEDULE
/
0001140361-25-001185
Stake: 56.90%
Shares: 96,660,341
CUSIP: 45258J102
Class: Common Stock, par value $0.0001 per share
Item 4 — Purpose of Transaction
Item 4 is hereby amended by adding the following to the end thereof: Roivant purchased an aggregate of 16,845,010 shares of Common Stock in the Private Placement to provide further capital to the Issuer for the advancement of the Issuer's development pipeline, working capital and other general corporate purposes, as well as to increase its ownership interest in the Issuer. As the Issuer's largest shareholder, Roivant may provide additional financing to the Issuer from time to time in the form of an investment in equity or debt securities of the Issuer or loans, including in connection with business development transactions or financing commitments in relation thereto.
Cross-References
Insider Activity (last 365d)
55 transactions
23 buys · 30 sales · 2 awards/exercises
Issuer Cluster
6 13D/G filings on this issuer
5 other filings besides this one
Filer Track Record
22 filings by this filer
21 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 16.72
17,758,956 shares short · -1.3% vs prior
Institutional Consensus · 2026-03-31
Held by elite portfolio managers
2 holders · $53.16M
DME Capital ManagementPoint72 Asset Mgmt
Post-Filing Returns · since 2025-01-13 on IMVT
Anchor price 40.09 on closest trading day on/after 2025-01-13. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
|---|
| 2026-05-20 |
Pande Atul |
director |
Option exercise |
6,000 |
$8.43 |
$51K |
| 2026-05-20 |
Pande Atul |
director |
Sale |
6,000 |
$32.00 |
$192K |
| 2026-05-01 |
Susman Robert Graham |
director |
Sale |
2,502 |
$27.17 |
$68K |
| 2026-04-23 |
Girao Tiago |
officer |
Sale |
25,760 |
$29.62 |
$763K |
| 2026-04-23 |
Stout Jay S |
officer |
Sale |
2,754 |
$29.62 |
$82K |
| 2026-04-08 |
Van Tuyl Christopher |
officer |
Sale |
5,165 |
$24.83 |
$128K |
| 2026-04-08 |
Gloria Melanie |
officer |
Sale |
8,722 |
$24.83 |
$217K |
| 2026-04-08 |
Stout Jay S |
officer |
Sale |
8,614 |
$24.83 |
$214K |
| 2026-04-08 |
Stout Jay S |
officer |
Sale |
1,518 |
$24.83 |
$38K |
| 2026-04-07 |
Torti Frank |
director |
Award |
174,189 |
— |
— |
| 2026-04-07 |
Fromkin Andrew J. |
director |
Award |
13,880 |
— |
— |
| 2026-04-07 |
Hughes Douglas J. |
director |
Award |
13,880 |
— |
— |
| 2026-04-07 |
Pande Atul |
director |
Award |
13,880 |
— |
— |
| 2026-04-07 |
Bauer Jake |
director |
Award |
13,880 |
— |
— |
| 2026-04-07 |
Susman Robert Graham |
director |
Award |
13,880 |
— |
— |
| 2026-04-07 |
Gloria Melanie |
officer |
Award |
83,671 |
— |
— |
| 2026-04-07 |
Stout Jay S |
officer |
Award |
66,937 |
— |
— |
| 2026-04-07 |
Van Tuyl Christopher |
officer |
Award |
41,343 |
— |
— |
| 2026-04-07 |
Venker Eric |
director, officer |
Award |
232,252 |
— |
— |
| 2026-04-07 |
Girao Tiago |
officer |
Award |
64,968 |
— |
— |
| 2026-04-07 |
Girao Tiago |
officer |
Award |
94,002 |
$24.61 |
$2.31M |
| 2026-04-07 |
Venker Eric |
director, officer |
Award |
336,043 |
$24.61 |
$8.27M |
| 2026-04-07 |
Van Tuyl Christopher |
officer |
Award |
59,820 |
$24.61 |
$1.47M |
| 2026-04-07 |
Stout Jay S |
officer |
Award |
96,851 |
$24.61 |
$2.38M |
| 2026-04-07 |
Gloria Melanie |
officer |
Award |
121,063 |
$24.61 |
$2.98M |
Showing 25 of 55
Other 13D/G Filings on Immunovant, Inc.
| Filed | Form | Filer | Stake | Shares | |
|---|
| 2023-10-04 |
SC |
Roivant Sciences Ltd. |
— |
— |
view → |
| 2021-08-02 |
SC |
Roivant Sciences Ltd. |
— |
— |
view → |
| 2021-03-08 |
SC |
Roivant Sciences Ltd. |
— |
— |
view → |
| 2020-09-04 |
SC |
Roivant Sciences Ltd. |
— |
— |
view → |
| 2020-05-15 |
SC |
Roivant Sciences Ltd. |
— |
— |
view → |
Other Filings by Roivant Sciences Ltd.
| Filed | Form | Issuer | Stake | Shares | |
|---|
| 2025-02-25 |
SCHEDULE |
Arbutus Biopharma Corp ABUS |
20.50% |
38,847,462 |
view → |
| 2025-02-18 |
SCHEDULE |
Arbutus Biopharma Corp ABUS |
20.50% |
38,847,462 |
view → |
| 2023-10-04 |
SC |
Immunovant, Inc. IMVT |
— |
— |
view → |
| 2021-10-20 |
SC |
Arbutus Biopharma Corp ABUS |
— |
— |
view → |
| 2021-08-02 |
SC |
Immunovant, Inc. IMVT |
— |
— |
view → |
| 2021-03-08 |
SC |
Immunovant, Inc. IMVT |
— |
— |
view → |
| 2020-09-04 |
SC |
Immunovant, Inc. IMVT |
— |
— |
view → |
| 2020-05-15 |
SC |
Immunovant, Inc. IMVT |
— |
— |
view → |
| 2019-12-31 |
SC |
Axovant Gene Therapies Ltd. |
— |
— |
view → |
| 2019-12-31 |
SC |
Myovant Sciences Ltd. |
— |
— |
view → |
| 2019-12-31 |
SC |
Urovant Sciences Ltd. |
— |
— |
view → |
| 2019-07-16 |
SC |
Urovant Sciences Ltd. |
— |
— |
view → |
| 2019-07-16 |
SC |
Arbutus Biopharma Corp ABUS |
— |
— |
view → |
| 2019-07-16 |
SC |
Myovant Sciences Ltd. |
— |
— |
view → |
| 2019-07-16 |
SC |
Axovant Gene Therapies Ltd. |
— |
— |
view → |
| 2019-03-19 |
SC |
Axovant Sciences Ltd. |
— |
— |
view → |
| 2018-04-23 |
SC |
Arbutus Biopharma Corp ABUS |
— |
— |
view → |
| 2018-04-12 |
SC |
Arbutus Biopharma Corp ABUS |
— |
— |
view → |
| 2018-03-16 |
SC |
Arbutus Biopharma Corp ABUS |
— |
— |
view → |
| 2018-02-14 |
SC |
Arbutus Biopharma Corp ABUS |
— |
— |
view → |
Showing 20 of 21
Want this depth on every filing the moment it hits SEC EDGAR?
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →